Kelly Gillespie, RN, JD, PhD
Professor; Center for Health Law Studies
School of Law
Secondary Appointment
Albert Gnaegi Center for Health Care Ethics
Education
PhD in Health Care Ethics, 麻豆传媒 (2015)
Juris Doctorate (certificate in health care law), 麻豆传媒 (2004)
Bachelor of Science in Nursing, 麻豆传媒 School (1991)
Practice Areas
Kelly Gillespie is an expert on health law, ethics, and policy and researches and writes on issues related to public health policy, drug use and controlled substances prescribing, pandemic ethics, and health inequities and discrimination.
Publications and Media Placements
Her work has been published in law and interdisciplinary journals including the Cato Supreme Court Review, Arizona State Law Review, American Journal of Bioethics, Journal of Addiction Medicine, and others. She is the co-editor and author of several chapters in 鈥淧rescription Drug Diversion and Pain: History, Policy, and Treatment鈥�, published by Oxford University Press. Throughout her career, she has been interviewed by many media outlets, including The New York Times, The Washington Post, the Associated Press, Blomberg, STAT News, LAW360, Vice.com, and NPR.
Professional Organizations and Associations
Gillespie is the co-chair of the American Bar Association鈥檚 Opioid Crisis Task Force and has co-authored two amici briefs before the United States Supreme Court in Ruan v U.S. regarding criminal distribution under The Controlled Substances Act as applied to prescribers.